Eastwood Competitors

Stocks . Canada . 
Stock . Eastwood Bio Medical Canada
EBM Stock  CAD 0.75  0.05  6.25%   
Eastwood Bio Medical competes with Maple Leaf, S A P, IShares Canadian, PHN Multi, and Altagas Cum; as well as few others. The company classifies itself under Consumer Staples Distribution & Retail sector and is part of Consumer Staples industry. Analyzing Eastwood Bio-Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Eastwood Bio-Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Eastwood Bio-Medical Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Eastwood Bio-Medical competition on your existing holdings.
  
Return On Equity is likely to climb to 0.85 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (1.22). At this time, Eastwood Bio-Medical's Non Current Assets Total are fairly stable compared to the past year. Asset Turnover is likely to climb to 1.21 in 2024, whereas Total Assets are likely to drop slightly above 418.2 K in 2024.
Hype
Prediction
LowEstimatedHigh
0.040.8122.86
Details
Intrinsic
Valuation
LowRealHigh
0.030.6322.68
Details

Eastwood Bio-Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Eastwood Bio-Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Eastwood and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Eastwood Bio Medical does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
TKU
+ 0.8
SAP
0P0000OXA6
+ 0.73
FINC
SOLR
+ 0.68
SAP
0P0000OXA6
+ 0.65
XHB
XHB
+ 0.62
FINC
EDGF
+ 0.57
FINC
  
High negative correlations   
0P0000OXA6
- 0.94
SAP
TKU
- 0.77
0P0000OXA6
TKU
- 0.73
XHB
TKU
- 0.72
FINC
FINC
- 0.72
SAP
XHB
- 0.64
SAP

Risk-Adjusted Indicators

There is a big difference between Eastwood Stock performing well and Eastwood Bio-Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Eastwood Bio-Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
MFI  1.05  0.01 (0.05) 0.18  1.37 
(1.17)
 2.31 
(2.30)
 8.39 
SAP  0.73 (0.26) 0.00 (3.24) 0.00 
 0.00 
 1.13 
(1.83)
 4.34 
FINC  0.11  0.01  0.00  0.60  0.00 
 0.00 
 0.37 
 0.00 
 2.23 
XHB  0.20  0.01 (0.41) 0.19  0.05 
(0.26)
 0.51 
(0.31)
 1.07 
EDGF  0.82  0.00 (0.06) 0.09  1.13 
(1.21)
 2.20 
(1.86)
 6.42 
SOLR  6.36  0.07  0.00  0.04  0.00 
 0.00 
 25.00 
(20.00)
 50.00 
0P0000OXA6  0.51  0.13  0.04  1.06  0.45 
(0.56)
 1.15 
(1.18)
 4.34 
ALA-PA  0.52  0.02 (0.11) 0.29  0.65 
(0.62)
 1.15 
(1.45)
 3.73 
ECO  1.51  0.07 (0.05)(0.01) 1.90 
(1.74)
 3.84 
(3.00)
 11.63 
TKU  6.36 (0.25) 0.00 (0.02) 0.00 
 0.00 
 25.00 
(25.00)
 83.33 

Cross Equities Net Income Analysis

Compare Eastwood Bio Medical and related stocks such as Maple Leaf Foods, Saputo Inc, and Forstrong Global Income Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
MFI(43.7 M)82.1 M115.3 M496.3 M709.9 M41.6 M181.7 M164.1 M101.3 M74.6 M113.3 M102.8 M(311.9 M)(125 M)(118.7 M)
SAP41 M380.8 M481.9 M533.1 M607.6 M601.1 M727.8 M852.5 M755.3 M582.8 M626 M274 M622 M265 M404.5 M
SOLR(43.6 K)(3.2 M)(11.3 M)(9.9 M)13.3 M5.5 M(3.2 M)(7.5 M)(2.3 M)(2.8 M)(1.4 M)(448.9 K)(2.7 M)(1.8 M)(1.9 M)
ECO(49.2 M)(252.7 M)(11.4 M)(14.8 M)(14.5 M)(14.4 M)(9.3 M)(6.4 M)(2.5 M)(345.4 K)(1.8 M)(3.1 M)(1.3 M)(2.8 M)(3 M)
TKU(527.6 K)(527.6 K)(527.6 K)(527.6 K)(441.9 K)(218.8 K)(657.7 K)(799.5 K)(827.2 K)(502.9 K)(2.6 M)(1.4 M)(1.4 M)(1.2 M)(1.3 M)

Eastwood Bio Medical and related stocks such as Maple Leaf Foods, Saputo Inc, and Forstrong Global Income Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Eastwood Bio Medical financial statement analysis. It represents the amount of money remaining after all of Eastwood Bio Medical Canada operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Eastwood Bio-Medical Competitive Analysis

The better you understand Eastwood Bio-Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Eastwood Bio-Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Eastwood Bio-Medical's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
EBM MFI SAP FINC XHB EDGF SOLR 0P0000OXA6 ALA-PA ECO
 6.25 
 0.75 
Eastwood
 1.64 
 22.75 
Maple
 0.85 
 26.10 
SAP
 0.41 
 21.62 
Forstrong
 1.07 
 19.91 
IShares
 1.61 
 10.71 
Brompton
 16.67 
 0.04 
Solar
 0.73 
 28.83 
PHN
 0.15 
 19.65 
Altagas
 1.00 
 3.96 
EcoSynthetix
Market Volatility
(90 Days Market Risk)
Out of control
Very steady
Very steady
Very steady
Very steady
Not too volatile
Out of control
Very steady
Very steady
Slightly risky
Market Performance
(90 Days Performance)
OK
Modest
Very Weak
OK
Good
Very Weak
Very Weak
Solid
Modest
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
About Average
Below Average
Low
Unknown
Low
About Average
Very High
Low
Low
Quite High
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Under Valued
Fairly Valued
Fairly Valued
Fairly Valued
Fairly Valued
Fairly Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Cautious Hold
Hold
Hold
Hold
Hold
Strong Sell
Strong Buy
Cautious Hold
Strong Sell
Current Ratio
3.42
1.67
1.72
N/A
N/A
0.19
N/A
N/A
30.53
Net Asset
489.14 K
4.6 B
14.26 B
430.05 M
N/A
1.8 M
5.64 B
21.59 B
42.84 M
Profit Margin
-0.74
0.0069
0.013
N/A
N/A
-0.0107
N/A
0.0239
-0.11
EBITDA
(398.19 K)
273.48 M
1.18 B
N/A
N/A
(762.93 K)
N/A
1.14 B
(3.24 M)
Operating Margin
-0.51
0.0538
0.0499
N/A
N/A
-0.7
N/A
0.0733
-0.0573
Current Valuation
51.72 M
4.61 B
14.47 B
N/A
N/A
8.9 M
N/A
N/A
187.91 M
Price To Book
2942.82
1.87
1.48
N/A
N/A
93.97
N/A
N/A
4.21
Retained Earnings
(5.54 M)
597.43 M
4.41 B
N/A
N/A
(68.87 M)
N/A
N/A
(459.55 M)
Current Asset
N/A
830.56 M
2.18 B
N/A
N/A
N/A
N/A
N/A
N/A
Five Year Return
N/A
1.6
1.54
2.9
N/A
N/A
8.42
N/A
N/A
One Year Return
N/A
N/A
N/A
12.5
N/A
N/A
-0.8
N/A
N/A
Beta
0.28
0.44
0.32
0.94
0.95
1.32
N/A
1.32
0.86
Number Of Employees
N/A
13.5 K
19.6 K
1
N/A
N/A
N/A
2.93 K
25
Cash Position Weight
N/A
N/A
N/A
N/A
N/A
N/A
1.58
N/A
N/A
Equity Positions Weight
N/A
N/A
N/A
N/A
N/A
N/A
98.42
N/A
N/A
Shares Outstanding
68.89 M
123.39 M
424.36 M
N/A
N/A
294.19 M
N/A
N/A
58.61 M
Three Year Return
N/A
N/A
N/A
2.4
N/A
N/A
5.68
N/A
N/A
Cash Flow From Operations
(16.89 K)
176.88 M
1.19 B
N/A
N/A
97.33 K
N/A
738 M
316.99 K
Annual Yield
N/A
0.0384
0.0294
N/A
N/A
N/A
N/A
0.0524
N/A
Total Debt
23.08 K
2.13 B
3.99 B
N/A
N/A
137.5 K
N/A
7.68 B
584.36 K
Return On Equity
-7.47
0.0221
0.0323
N/A
N/A
-6.84
N/A
0.0477
-0.0429
Bond Positions Weight
N/A
N/A
N/A
97.03
N/A
N/A
N/A
N/A
N/A
Holdings Turnover
N/A
N/A
N/A
30.71
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.64
0.0325
0.0397
N/A
N/A
-0.25
N/A
0.0273
-0.0579
Number Of Shares Shorted
63
656.54 K
2.68 M
N/A
N/A
1.21 K
N/A
8.1 K
399.87 K
Book Value Per Share
-0.017
12.26
17.49
N/A
N/A
-0.007
N/A
24.88
0.68
Minimum Initial Investment
N/A
N/A
N/A
N/A
N/A
N/A
500
N/A
N/A
Current Liabilities
N/A
329.12 M
1.36 B
N/A
N/A
N/A
N/A
N/A
N/A
Total Asset
489.14 K
4.6 B
14.26 B
430.05 M
N/A
1.8 M
5.64 B
21.59 B
42.84 M
Short Ratio
0.05
3.34
6.42
N/A
N/A
0.58
N/A
1.62
11.05
Debt To Equity
N/A
0.51
0.68
N/A
N/A
N/A
N/A
N/A
2.7
Target Price
N/A
29.8
32.15
N/A
N/A
1.15
N/A
N/A
8.39
Last Dividend Paid
N/A
0.87
0.75
0.065
N/A
N/A
N/A
1.05
N/A
Shares Owned By Institutions
N/A
26.18
25.66
N/A
N/A
N/A
N/A
52.87
14.73
Market Capitalization
51.66 M
2.85 B
10.98 B
N/A
N/A
10.3 M
N/A
N/A
234.43 M
Price To Earning
-11.43
29.58
22.33
N/A
N/A
N/A
N/A
N/A
-18.42
Price To Earnings To Growth
N/A
1.59
0.65
N/A
N/A
N/A
N/A
N/A
N/A
Price To Sales
79.05
0.59
0.61
N/A
N/A
1.19
N/A
N/A
14.7
Net Income
(546.6 K)
(124.98 M)
265 M
N/A
N/A
(1.81 M)
N/A
283 M
(2.82 M)
Earnings Per Share
-0.01
0.27
0.56
N/A
N/A
N/A
N/A
0.89
-0.04
Shares Owned By Insiders
69.55
39.9
40.45
N/A
N/A
42.24
N/A
N/A
14.48
Revenue
867.94 K
4.87 B
17.34 B
N/A
N/A
7.47 M
N/A
10.57 B
12.66 M
Working Capital
(1.18 M)
179.04 M
1.7 B
N/A
N/A
(2.31 M)
N/A
N/A
36.96 M
Ten Year Return
N/A
N/A
N/A
3.5
N/A
N/A
N/A
N/A
N/A
Cash And Equivalents
708.26 K
91.08 M
263 M
N/A
N/A
403.2 K
N/A
N/A
44.59 M
Cash Per Share
0.01
1.45
1.59
N/A
N/A
N/A
N/A
N/A
0.76
Gross Profit
902.74 K
424.14 M
1.16 B
N/A
N/A
663.58 K
N/A
2.87 B
4.15 M
Day Typical Price
0.75
22.9
26.08
21.62
19.87
10.71
0.0333
28.83
19.62
3.93
Accumulation Distribution
N/A
6053.19
7894.39
N/A
62.14
N/A
34102.0
N/A
30.53
175.06
Daily Balance Of Power
(9,223,372,036,855)
(0.59)
0.6667
(9,223,372,036,855)
1.615385
9.2 T
1.0
9.2 T
0.375
(0.33)
Period Momentum Indicator
(0.05)
(0.38)
0.22
(0.09)
0.21
0.17
0.005
0.21
0.03
(0.04)
Rate Of Daily Change
0.94
0.98
1.01
1.0
1.01
1.02
1.17
1.01
1.0
0.99
Day Median Price
0.75
22.98
26.07
21.62
19.85
10.71
0.0325
28.83
19.61
3.92
Price Action Indicator
(0.03)
(0.42)
0.15
(0.04)
0.17
0.085
0.005
0.1
0.055
0.02
Relative Strength Index
31.3
66.23
29.69
57.36
72.59
63.94
44.23
73.41
48.79
36.66
Coefficient Of Variation
972.15
2948.79
(398.34)
1001.74
762.76
4494.15
(48,960)
482.51
1811.75
12231.42
Mean Deviation
10.78
1.05
0.7323
0.108
0.1965
0.8213
6.36
0.5093
0.5239
1.51
Jensen Alpha
2.62
0.0144
(0.26)
0.0127
0.0084
(0)
0.0733
0.1257
0.0175
0.0671
Total Risk Alpha
(1.05)
(0.19)
(0.39)
(0.02)
(0.01)
(0.17)
(1.90)
0.0313
(0.08)
(0.30)
Sortino Ratio
0.1035
(0.05)
N/A
N/A
(0.41)
(0.06)
N/A
0.036
(0.11)
(0.05)
Downside Variance
414.21
2.03
N/A
N/A
0.0523
2.86
N/A
0.512
0.5713
4.2
Standard Deviation
21.71
1.5
0.9525
0.2582
0.2454
1.26
12.36
0.7292
0.7108
2.04
Kurtosis
14.72
3.4
0.1698
11.6
(0.06)
1.25
1.21
3.83
0.9515
1.15
Potential Upside
25.0
2.31
1.13
0.3705
0.5092
2.2
25.0
1.15
1.15
3.84
Treynor Ratio
(0.65)
0.178
(3.24)
0.5952
0.1857
0.0915
0.0375
1.06
0.2863
(0.01)
Maximum Drawdown
150.12
8.39
4.34
2.23
1.07
6.42
50.0
4.34
3.73
11.63
Variance
471.12
2.26
0.9072
0.0667
0.0602
1.58
152.86
0.5317
0.5053
4.14
Market Risk Adjusted Performance
(0.64)
0.188
(3.23)
0.6052
0.1957
0.1015
0.0475
1.07
0.2963
(0)
Risk Adjusted Performance
0.0885
0.0309
(0.19)
0.0568
0.0792
0.021
0.0078
0.1583
0.0415
0.0125
Skewness
2.96
0.0543
(0.45)
0.6384
0.5027
(0.40)
0.4358
0.5676
(0.27)
(0.05)
Semi Deviation
10.94
1.37
N/A
N/A
0.0476
1.13
N/A
0.4513
0.6455
1.9
Information Ratio
0.0971
(0.05)
(0.38)
(0.39)
(0.38)
(0.08)
(0.01)
0.0353
(0.12)
(0.05)
Value At Risk
(23.47)
(2.30)
(1.83)
N/A
(0.31)
(1.86)
(20.00)
(1.18)
(1.45)
(3.00)
Expected Short fall
(24.44)
(1.17)
N/A
N/A
(0.26)
(1.21)
N/A
(0.56)
(0.62)
(1.74)
Downside Deviation
20.35
1.43
N/A
N/A
0.2286
1.69
N/A
0.7155
0.7558
2.05
Semi Variance
119.71
1.86
N/A
N/A
0.0023
1.27
N/A
0.2036
0.4167
3.6

Eastwood Bio-Medical Competition Performance Charts

Five steps to successful analysis of Eastwood Bio-Medical Competition

Eastwood Bio-Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Eastwood Bio Medical in relation to its competition. Eastwood Bio-Medical's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Eastwood Bio-Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Eastwood Bio-Medical's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Eastwood Bio Medical, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Eastwood Bio-Medical position

In addition to having Eastwood Bio-Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Diversified Assets Thematic Idea Now

Diversified Assets
Diversified Assets Theme
Pablicly traded close-end funds and other entities backed by different types of diversified investments. The Diversified Assets theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Diversified Assets Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Eastwood Stock Analysis

When running Eastwood Bio-Medical's price analysis, check to measure Eastwood Bio-Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio-Medical is operating at the current time. Most of Eastwood Bio-Medical's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio-Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio-Medical's price. Additionally, you may evaluate how the addition of Eastwood Bio-Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY